Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
about
Monocyte Heterogeneity: Consequences for Monocyte-Derived Immune CellsMethotrexate and low-dose prednisolone downregulate osteoclast function by decreasing receptor activator of nuclear factor-κβ expression in monocytes from patients with early rheumatoid arthritis.Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis.TNF-α has both stimulatory and inhibitory effects on mouse monocyte-derived osteoclastogenesisGap junctional communication is involved in differentiation of osteoclasts from bone marrow and peripheral blood monocytes.Peripheral blood monocytes show increased osteoclast differentiation potential compared to bone marrow monocytes
P2860
Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
@en
Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
@nl
type
label
Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
@en
Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
@nl
prefLabel
Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
@en
Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
@nl
P2093
P2860
P356
P1476
Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
@en
P2093
Sara Sprangers
Vincent Everts
Yixuan Cao
P2860
P304
P356
10.1002/JCP.25220
P577
2015-11-09T00:00:00Z